Delivery Order SPE2DB20D3101-SPE2DB25FRUM8
- Not listed
- The Defense Logistics Agency awarded a $3,057 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This contract, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a competitively awarded, non-set-aside delivery order supporting federal medical procurement requirements. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,979.82 and an ultimate completion date of August 6, 2025. The contract was competitively awarded with no set-aside designation, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $4,486.90 and a completion date of August 1, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $14,519.62 to AmerisourceBergen Drug Corp for the supply of Azithromycin 500 mg tablets in quantities of 30, with a firm fixed price and completion deadline of September 11, 2025. This non-set-aside competitive award was issued to AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania, where the products will be delivered. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a $2,604.70 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This contract utilizes a firm fixed price structure with no set-aside designation, indicating it was competitively awarded. The order is scheduled for completion by September 18, 2025, with performance taking place at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Azithromycin 250 mg tablets in quantities of 30 units. This delivery order, valued at $1,255.04 with a firm fixed price structure, represents a non-competitive set-aside award and is scheduled for completion by September 17, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,366.40 to AmerisourceBergen Drug Corp for the supply of Azithromycin 500 mg tablets in quantities of 30, with an ultimate completion date of September 10, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This non-set-aside, competitively awarded contract is structured as a firm fixed-price delivery order with a ceiling value of $8,163.90 and an ultimate completion date of September 11, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,508.50 to AmerisourceBergen Drug Corp for the supply of Azithromycin 500 mg tablets in quantities of 30 units. This competitive award, issued on July 23, 2025, with an ultimate completion date of July 24, 2025, represents a firm fixed price delivery order with no set-aside designation. The pharmaceutical products will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Azithromycin 500 mg tablets in quantities of 100 units, with a contract ceiling value of $1,051.00. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRUM8Delivery Order
The Defense Logistics Agency awarded a $5,380.00 delivery order to AmerisourceBergen Drug Corp for Azithromycin 500 mg tablets on September 5, 2025, with an ultimate completion date of September 8, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company's extensive portfolio of federal contracts demonstrates its capability to meet Department of Defense medical supply requirements across multiple therapeutic domains, including antibiotics, specialty medications, vaccines, and medical devices. This Azithromycin order represents a routine pharmaceutical delivery under the DLA's broader medical supply chain operations, which distribute essential medications and medical commodities to Defense Health Agency facilities, the U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.4k | 9/5/25 |